Showing results (531-540 of 602) with videos related to

Sort By:
Pageof 61
Cancer Causes & Control : CCC|September 3, 2021
Temporal trends, tumor characteristics and stage-specific survival in penile non-squamous cell carcinoma vs. squamous cell carcinomaMike Wenzel, Nicolas Siron, Claudia Collà Ruvolo, et al.
Diabetologia|February 19, 2009
A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humansA Kotronen, L E Johansson, L M Johansson, et al.
Human Molecular Genetics|November 5, 2004
Orexin loss in Huntington's diseaseAsa Petersén, Joana Gil, Marion L C Maat-Schieman, et al.
European Journal of Neurology|July 14, 2011
Basal ganglia volume is strongly related to P3 event-related potential in premanifest Huntington's diseaseC K Jurgens, K van der Hiele, R H A M Reijntjes, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2021
Sex- and Age-Related Differences in the Distribution of Metastases in Patients With Upper Urinary Tract Urothelial CarcinomaMarina Deuker, Giuseppe Rosiello, Lara Franziska Stolzenbach, et al.
Brain and Behavior|March 14, 2023
Progressive alterations in white matter microstructure across the timecourse of Huntington's diseaseCarlos Estevez-Fraga, Michael S Elmalem, Marina Papoutsi, et al.
Marine Environmental Research|June 24, 2025
Population connectivity of vulnerable Brazilian parrotfishesKaris Itchel Tuñón Valdés, Juliana Beltramin De Biasi, Natalia C Roos, et al.
Virchows Archiv : an International Journal of Pathology|September 3, 2014
Clinical behavior of chromophobe renal cell carcinoma is less aggressive than that of clear cell renal cell carcinoma, independent of Fuhrman grade or tumor sizeSandra Steffens, Frederik C Roos, Martin Janssen, et al.
European Journal of Human Genetics : EJHG|January 29, 2015
Huntington's disease biomarker progression profile identified by transcriptome sequencing in peripheral bloodAnastasios Mastrokolias, Yavuz Ariyurek, Jelle J Goeman, et al.
Pageof 61